With your own knowledge and the help of the following document:

Document 1 (Title: Fundamentals of Single-Gene Metabolic Diseases): Phenylketonuria (PKU) represents a paradigmatic inborn error of metabolism caused by mutations in the phenylalanine hydroxylase (PAH) gene, resulting in deficient conversion of phenylalanine to tyrosine. The condition exemplifies several fundamental genetic principles that govern monogenic disorders. While variable expressivity describes differing phenotypic severity among individuals with the same mutation, anticipation refers to progressively earlier onset or increasing severity across generations, a phenomenon not observed in most metabolic disorders. Multiple gene mutations, though responsible for some complex traits, do not explain the diverse manifestations of PKU, which result from a single gene defect. Rather, pleiotropy—the phenomenon where a single gene produces multiple, seemingly unrelated phenotypic effects—explains the constellation of clinical features. In PKU, elevated phenylalanine and its metabolites act through numerous biochemical pathways to produce apparently disparate manifestations: hypophenylalaninemia causes hypopigmentation through reduced melanin synthesis; neurotoxic effects of phenylalanine and its metabolites lead to intellectual disability, seizures, and microcephaly; competitive inhibition of amino acid transporters results in abnormal protein synthesis; and characteristic musty odor derives from phenylacetic acid excretion. The multisystem effects all trace back to the primary biochemical defect, demonstrating how one gene affects multiple phenotypic features through interconnected pathways. Early diagnosis through newborn screening permits dietary intervention before irreversible neurological damage occurs, though treatment burden and compliance challenges remain substantial throughout the lifespan.
Document 2 (Title: Psychodynamic Approaches to Adolescent Behavioral Changes): Defense mechanisms represent unconscious psychological operations that protect individuals from unacceptable thoughts, impulses, or emotions. While serving adaptive functions in maintaining psychological equilibrium, these mechanisms can become maladaptive when excessively rigid or immature. Adolescence represents a developmental period characterized by significant psychological reorganization and heightened vulnerability to psychological distress, often accompanied by prominent deployment of defense mechanisms. The repertoire and maturity of defense mechanisms employed evolve throughout development, with more primitive mechanisms predominating earlier and more mature mechanisms emerging with psychological development. Acting out describes a particular defense mechanism involving the expression of unconscious emotional conflicts through behavior rather than verbal articulation or conscious awareness. This mechanism typically manifests as impulsive actions that serve to discharge tensions associated with conflictual feelings, thus temporarily reducing anxiety while avoiding conscious confrontation with the underlying conflict. In adolescents experiencing significant family disruption, such as parental separation or divorce, acting out behaviors may represent unconscious expressions of anger, abandonment anxiety, or attempts to regain control in an environment perceived as unstable. The clinical presentation typically involves a marked behavioral change from previous patterns, with conduct that appears purposefully provocative or self-destructive, including truancy, substance use, sexual acting out, or aggressive behaviors. This contrasts with other defense mechanisms including projection, wherein unacceptable internal impulses are attributed to others; passive aggression, where resistance manifests through passive means including procrastination or intentional inefficiency; and regression, characterized by reversion to earlier developmental behaviors in response to stress. Treatment approaches incorporate both supportive interventions addressing immediate behavioral concerns and exploratory techniques to enhance self-awareness regarding underlying emotional conflicts.
Document 3 (Title: Genetic Basis and Clinical Management of Coagulopathies): Hemophilia represents a group of hereditary coagulation disorders with distinctive genetic, laboratory, and clinical characteristics determining diagnosis, management approaches, and potential complications. Genetic analysis reveals predominantly X-linked inheritance patterns, with affected males inheriting maternal mutations while females typically serve as asymptomatic carriers due to X-chromosome inactivation patterns. This sex-linked transmission creates characteristic family distribution patterns distinct from autosomal inheritance disorders. Clinical presentation typically develops gradually rather than appearing immediately at birth, with diagnosis often occurring after progressive recognition of excessive bruising, joint bleeding, or prolonged bleeding following minor trauma or surgical procedures during early childhood. Laboratory evaluation reveals specific factor deficiencies, with hemophilia A demonstrating factor VIII deficiency while hemophilia B (Christmas disease) results from factor IX deficiency rather than alterations in factor X levels. Contemporary management approaches employ factor replacement therapy using either plasma-derived or recombinant clotting factor concentrates, though approximately 20-30% of severely affected individuals develop neutralizing alloantibodies (inhibitors) following repeated exposure to replacement therapy. These inhibitors represent a major treatment complication necessitating alternative hemostatic approaches including bypassing agents or immune tolerance induction protocols. Advances in molecular diagnostics have enabled expanded genetic screening capabilities, allowing carrier detection and prenatal diagnosis through chorionic villus sampling or amniocentesis when desired by affected families. These diagnostic capabilities facilitate informed reproductive decision-making and early intervention planning for affected pregnancies. Ongoing research explores gene therapy approaches potentially offering definitive treatment through targeted genetic modification of hepatocytes to enable endogenous clotting factor production.

Answer the following multiple-choice question.
Question: A 9-month-old female is brought to the emergency department after experiencing a seizure. She was born at home and was normal at birth according to her parents. Since then, they have noticed that she does not appear to be achieving developmental milestones as quickly as her siblings, and often appears lethargic. Physical exam reveals microcephaly, very light pigmentation (as compared to her family), and a "musty" body odor. The varied manifestations of this disease can most likely be attributed to which of the following genetic principles?
Options:
A. Anticipation
B. Multiple gene mutations
C. Pleiotropy
D. Variable expressivity

Respond strictly in valid JSON format as follows:
{"answer_choice": "A"} ← if A is the answer
Output only the JSON object. Do not include any explanation, commentary, markdown, or extra text.